华法林管理的不断演变模式：抗凝门诊、患者自我监测和患者自我管理。 - Suppr

Suppr

超能文献

Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management.

作者信息

Ansell J E, Hughes R

出版信息

Am Heart J. 1996 Nov;132(5):1095-100. doi: 10.1016/s0002-8703(96)90040-x.

DOI:10.1016/s0002-8703(96)90040-x

PMID:8892802

Abstract

摘要

相似文献

Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management.华法林管理的不断演变模式：抗凝门诊、患者自我监测和患者自我管理。

Am Heart J. 1996 Nov;132(5):1095-100. doi: 10.1016/s0002-8703(96)90040-x.

Self-managed oral anticoagulation therapy.自我管理的口服抗凝治疗。

CMAJ. 2007 Mar 13;176(6):813; author reply 813-4. doi: 10.1503/cmaj.1060152.

SMART: self-management of anticoagulation, a randomised trial [ISRCTN19313375].SMART：抗凝自我管理，一项随机试验[国际标准随机对照试验编号19313375]

BMC Fam Pract. 2003 Sep 18;4:11. doi: 10.1186/1471-2296-4-11.

The economics of anticoagulation: what are the issues?抗凝治疗的经济学：问题有哪些？

Am J Manag Care. 2004 Oct;10(10 Suppl):S292-6.

Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.抗凝治疗患者的自我监测：临床实践应用的相关考虑。

Pharmacotherapy. 2011 Dec;31(12):1161-74. doi: 10.1592/phco.31.12.1161.

Patient self management of oral anticoagulation in routine care in the UK.英国常规护理中口服抗凝药的患者自我管理

J Clin Pathol. 2007 Nov;60(11):1263-7. doi: 10.1136/jcp.2006.044008. Epub 2007 Jan 26.

Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.新型口服抗凝药用于房颤患者卒中预防的成本效益：取决于华法林抗凝控制的质量

Pharmacoeconomics. 2015 Apr;33(4):395-408. doi: 10.1007/s40273-014-0246-7.

Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.临床环境中房颤患者华法林治疗的抗凝控制质量及监测成本：一项多中心管理式医疗研究

Ann Pharmacother. 2005 Mar;39(3):446-51. doi: 10.1345/aph.1E169. Epub 2005 Feb 8.

MCOs following innovative CMS remote monitoring initiative: self-testing service is designed to lower costs and improve outcomes for anticoagulation therapy.

Manag Care Q. 2006 Winter;14(1):13-6.

Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.泰国药师参与华法林治疗管理的成本效益分析。

Thromb Res. 2013 Oct;132(4):437-43. doi: 10.1016/j.thromres.2013.08.019. Epub 2013 Sep 1.

引用本文的文献

A regional anticoagulation program improves safety and outcomes for both children and adults.区域性抗凝项目可提高儿童和成人的安全性和治疗效果。

J Thromb Thrombolysis. 2023 Jul;56(1):27-36. doi: 10.1007/s11239-023-02806-w. Epub 2023 Apr 24.

Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina.阿根廷抗凝患者中实施抗凝诊所和即时检测监测设备的成本效用及预算影响分析

Pharmacoecon Open. 2022 Sep;6(5):657-668. doi: 10.1007/s41669-022-00352-4. Epub 2022 Jul 14.

Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed-methods study.将直接口服抗凝剂纳入抗凝门诊护理的障碍：一项混合方法研究。

Res Pract Thromb Haemost. 2018 Oct 19;3(1):79-84. doi: 10.1002/rth2.12157. eCollection 2019 Jan.

Structure and function of anticoagulation clinics in the United States: an AC forum membership survey.美国抗凝门诊的结构和功能：AC 论坛会员调查。

J Thromb Thrombolysis. 2018 Jul;46(1):7-11. doi: 10.1007/s11239-018-1652-z.

Oral anticoagulation with vitamin K inhibitors and determinants of successful self-management in primary care.维生素K抑制剂的口服抗凝治疗及初级保健中成功自我管理的决定因素

BMC Cardiovasc Disord. 2016 Sep 13;16(1):180. doi: 10.1186/s12872-016-0326-z.

Self-monitoring and self-management of oral anticoagulation.口服抗凝治疗的自我监测与自我管理

Cochrane Database Syst Rev. 2016 Jul 5;7(7):CD003839. doi: 10.1002/14651858.CD003839.pub3.

Regulatory, legislative, and policy updates with anticoagulant use.抗凝剂使用方面的监管、立法及政策更新。

J Thromb Thrombolysis. 2015 Apr;39(3):273-87. doi: 10.1007/s11239-015-1198-2.

Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials.华法林处于治疗范围时间对卒中及大出血发生率的影响评估及其对与新型口服抗凝药使用相关的医疗费用节省的影响——来自ARISTOTLE、ROCKET-AF及RE-LY试验的经验教训

J Thromb Thrombolysis. 2014;38(2):150-9. doi: 10.1007/s11239-013-1048-z.

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic.在药剂师管理的抗凝门诊开始接受达比加群酯治疗的患者中的不良事件。

Pharm Pract (Granada). 2013 Apr;11(2):90-5. doi: 10.4321/s1886-36552013000200005. Epub 2013 Jun 30.

Study on Impact of Clinical Pharmacist's Interventions in the Optimal Use of Oral Anticoagulants in Stroke Patients.临床药师干预对卒中患者口服抗凝剂合理使用的影响研究

Indian J Pharm Sci. 2013 Jan;75(1):53-9. doi: 10.4103/0250-474X.113550.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验